Substance Use and Addiction Disorders
Benefits of Buprenorphine in Opioid Use Disorder:
Reduction of Cravings and Withdrawal Symptoms: Buprenorphine is a partial opioid agonist, meaning it binds to opioid receptors in the brain to reduce cravings and withdrawal symptoms without producing the same intense high as full agonists like heroin or oxycodone.
​
Reduction of Cravings and Withdrawal Symptoms: Buprenorphine is a partial opioid agonist, meaning it binds to opioid receptors in the brain to reduce cravings and withdrawal symptoms without producing the same intense high as full agonists like heroin or oxycodone.
​​​Stabilization of Opioid Dependence: It helps to stabilize individuals with OUD by preventing opioid withdrawal symptoms, allowing them to function normally without the need for illicit opioids.
​
Reduction in Illicit Opioid Use: Treatment with buprenorphine has been shown to significantly decrease the use of illicit opioids, reducing the risk of overdose and other associated harms.
​
Lower Risk of Infectious Diseases: By reducing injection drug use and risky behaviors associated with obtaining illicit opioids, buprenorphine treatment can lower the risk of infectious diseases such as HIV and hepatitis C.
Vivitrol (Naltrexone)
The efficacy of Vivitrol (naltrexone) in the treatment of alcohol use disorder (AUD) and opioid use disorder (OUD) is supported by numerous clinical trials and research studies. Some major research findings include:
Vivitrol for Alcohol Use Disorder:
​The COMBINE Study: This landmark clinical trial, conducted by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), evaluated the effectiveness of various treatments for AUD, including Vivitrol.
​
​​It found that Vivitrol was effective in reducing heavy drinking days and increasing periods of abstinence when compared to placebo.
​​A Multi-Site, Open-Label Study: This study assessed the safety and efficacy of Vivitrol in patients with AUD. It found that Vivitrol treatment was associated with a reduction in heavy drinking days and improved overall drinking outcomes.
Vivitrol for Opioid Use Disorder:
​​The COMBINE Study Extension: In an extension of the COMBINE Study, researchers investigated the long-term efficacy of Vivitrol in individuals with OUD. They found that Vivitrol was effective in preventing relapse to opioid use and improving treatment outcomes over an extended period.​
​A Randomized Controlled Trial: This study compared Vivitrol to other medications for OUD, such as methadone and buprenorphine. It found that Vivitrol was non-inferior to these medications in terms of reducing opioid use and preventing relapse.
​
Real-World Observational Studies: Several real-world studies have evaluated the effectiveness of Vivitrol in clinical practice settings. These studies have consistently demonstrated the benefits of Vivitrol in reducing opioid use, preventing relapse, and improving treatment retention.
​
Overall, the research supporting Vivitrol's efficacy in the treatment of AUD and OUD underscores its role as an important therapeutic option for individuals seeking recovery from substance use disorders. These findings provide robust evidence for the use of Vivitrol as part of a comprehensive treatment approach that includes counseling, behavioral therapies, and other supportive interventions.
Substance Abuse Counseling
We recognize that addressing substance use disorders requires a comprehensive approach that goes beyond medication alone. That's why we emphasize the importance of combining medication-assisted treatment (MAT) with individual and group substance abuse counseling to support our patients on their journey to lasting recovery.
​​Why Counseling Matters
Substance abuse counseling plays a crucial role in addressing the underlying psychological, social, and behavioral factors contributing to addiction. Counseling provides individuals with the opportunity to explore their thoughts, emotions, and behaviors related to substance use in a supportive and non-judgmental environment.
​
The Benefits of Combined Treatment
By integrating counseling with medication-assisted treatment, we can address both the physical and psychological aspects of addiction simultaneously. This holistic approach not only helps individuals manage cravings and withdrawal symptoms more effectively but also equips them with the coping skills and strategies needed to navigate triggers, stressors, and life challenges without resorting to substance use.
​
Our Collaborative Approach
At Conquest Health, we believe in the power of collaboration. Our practice coordinates closely with experienced substance abuse counselors and therapists to ensure that our patients receive comprehensive and personalized care. Through close communication and shared treatment goals, we strive to provide our patients with the highest quality of care and support throughout their recovery journey.